Tiazesim
Discontinued antidepressant medication
- None
- In general: ℞ (Prescription only)
- 5-[2-(dimethylamino)ethyl]-2-phenyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
- 5845-26-1
3122-01-8 (hydrochloride)
- 22107
- 20775 Y
- 44G76ZB85O
- D02699 Y
- ChEMBL2111123 Y
- DTXSID30863620
- Interactive image
- CN(C)CCN1C(=O)CC(SC2=CC=CC=C21)C3=CC=CC=C3
InChI
- InChI=1S/C19H22N2OS/c1-20(2)12-13-21-16-10-6-7-11-17(16)23-18(14-19(21)22)15-8-4-3-5-9-15/h3-11,18H,12-14H2,1-2H3
- Key:QJJXOEFWXSQISU-UHFFFAOYSA-N
Tiazesim (INNTooltip International Nonproprietary Name), or thiazesim (BANTooltip British Approved Name, USANTooltip United States Adopted Name), previously sold under the brand name Altinil, is a heterocyclic antidepressant related to the tricyclic antidepressants (TCAs) which, introduced in 1966 by Squibb Corporation (now Bristol-Myers Squibb), has since been discontinued and is no longer marketed.[1][2]
See also
- Diltiazem
- Tofenacin
References
- v
- t
- e
Specific reuptake inhibitors and/or receptor modulators | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
Miscellaneous | |
---|---|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e